Every Form 4 that Travelers Compan (TRV) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow TRV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TRV filings page.
The Travelers Companies, Inc. executive Diane Kurtzman, EVP & Chief HR Officer, reported a grant of stock options. On 02/03/2026 she acquired 6,060 stock options, each giving the right to buy common stock at an exercise price of $288.23 per share.
These options, covering 6,060 shares of common stock, are exercisable from 02/03/2029 and expire on 02/03/2036. Following this grant, she beneficially owns 6,060 derivative securities directly.
The Travelers Companies, Inc. reported an insider equity award for executive Mojgan M. Lefebvre, EVP & Chief Tech & Ops Officer. The Form 4 shows a grant of 10,651 stock options (Right to Buy) on February 3, 2026.
These options allow the purchase of Travelers common stock at an exercise price of $288.23 per share. They become exercisable on February 3, 2029 and expire on February 3, 2036. Following this transaction, Lefebvre is reported as directly owning 10,651 derivative securities in the form of these options.
Travelers Companies executive Maria Olivo, EVP, ERM & Chief Risk Officer, received a grant of stock options on February 3, 2026. The award covers 10,773 stock options with a conversion or exercise price of $288.23 per share.
These options give the right to buy Travelers common stock and become exercisable on February 3, 2029, with an expiration date of February 3, 2036. Following this transaction, Olivo directly holds 10,773 derivative securities of this type.
The Travelers Companies, Inc. executive Jeffrey P. Klenk, EVP & President, Bond & Specialty Insurance, reported an award of stock options. On February 3, 2026, he acquired 12,854 stock options with a $288.23 exercise price, each for one share of common stock.
These options become exercisable on February 3, 2029 and expire on February 3, 2036. Following this grant, Klenk beneficially owns 12,854 derivative securities directly, as reflected in the filing.
The Travelers Companies, Inc. executive Rowland David Donnay, EVP & Co-Chief Investment Officer, reported a new stock option grant. On February 3, 2026, he was awarded 7,407 stock options with a conversion or exercise price of $288.23 per share.
These options relate to Travelers common stock, are held directly, and expire on February 3, 2036. Following this grant, Donnay beneficially owns 7,407 derivative securities in the form of these stock options.
The Travelers Companies, Inc. executive Michael Frederick Klein, EVP & President, Personal Insurance, reported acquiring stock options on the company’s common stock. On February 3, 2026, he acquired 16,649 stock options (right to buy) with a conversion or exercise price of $288.23 per share.
These options become exercisable on February 3, 2029 and expire on February 3, 2036. After this transaction, Klein beneficially owned 16,649 derivative securities, held directly in his name, with the derivative securities themselves reported at a price of $0.
The Travelers Companies, Inc. reported an insider equity award for its EVP & Chief Financial Officer, Daniel S. Frey. On February 3, 2026, he was granted stock options to buy 13,026 shares of Travelers common stock.
The options have an exercise price of $288.23 per share, become exercisable on February 3, 2029, and expire on February 3, 2036. Following this grant, Frey directly holds 13,026 stock options, with no indirect ownership reported in this filing.
The Travelers Companies, Inc. executive Yin Daniel Tei-Hwa, EVP & Co-Chief Investment Officer, reported a stock option award. On 02/03/2026, he received 7,407 stock options with an exercise price of $288.23 per share, expiring between 02/03/2029 and 02/03/2036.
Following this grant, he beneficially owns 7,407 derivative securities directly.
Travelers Companies executive Gregory C. Toczydlowski received a new stock option grant. On February 3, 2026, he was awarded 17,629 stock options to buy Travelers common stock at an exercise price of $288.23 per share. These options become exercisable on February 3, 2029 and expire on February 3, 2036. Following this award, he beneficially owns 17,629 derivative securities directly.
Travelers Companies’ Chairman and CEO Alan D. Schnitzer reported multiple equity transactions in early February 2026. On February 4, 2026, he exercised 216,246 stock options at $126.18 per share, receiving the same number of common shares.
That day, Schnitzer had 160,513 shares withheld to cover obligations at $294.36 per share and sold additional common stock in three blocks: 26,509 shares at $294.1802, 23,078 shares at $295.0001, and 6,146 shares at $295.8154, based on weighted-average pricing ranges. After these trades, he directly owned 260,329.401 shares of Travelers common stock.
Separately, on February 3, 2026, Schnitzer was granted 88,389 stock options with an exercise price of $288.23, exercisable beginning February 3, 2029 and expiring February 3, 2036. The filing also notes 11,091 shares held indirectly by his spouse, for which he disclaims beneficial ownership.
The Travelers Companies, Inc. reported that EVP and Chief Admin Officer Andy F. Bessette received a grant of stock options. On February 3, 2026, he was awarded options to buy 6,427 shares of Travelers common stock at an exercise price of $288.23 per share.
These options relate to 6,427 underlying common shares, become exercisable on February 3, 2029, and expire on February 3, 2036. Following this grant, Bessette directly beneficially owns 6,427 derivative securities in the form of these stock options.
The Travelers Companies, Inc. reported that executive Avrohom J. Kess, Vice Chairman and Chief Legal Officer, received a grant of stock options. On February 3, 2026, he was awarded options to buy 14,691 shares of Travelers common stock at an exercise price of $288.23 per share.
The options become exercisable on February 3, 2029 and expire on February 3, 2036. After this grant, Kess beneficially owns 14,691 derivative securities directly in the form of these stock options.
The Travelers Companies, Inc. director David Scott Williams reported an automatic award of deferred stock units. On 02/03/2026, he received 729 deferred stock units of Travelers common stock at $288.23 per unit under the company’s Amended and Restated 2023 Stock Incentive Plan and Deferred Compensation Plan for Non-Employee Directors.
These deferred stock units convert into an equal number of common shares when distributed, which occurs in a lump sum or annual installments beginning at least six months after his board service ends. Following this grant, Williams beneficially owns 2,478.196 deferred stock units directly, including 27.39 units accumulated through dividend reinvestment since February 4, 2025.
The Travelers Companies, Inc. director Bridget A. van Kralingen reported an award of 729 shares of common stock in the form of deferred stock units on February 3, 2026 at $288.23 per share. After this grant, she beneficially owns 4,622.338 common shares on a direct basis.
The deferred stock units were granted under Travelers’ Amended and Restated 2023 Stock Incentive Plan and its Deferred Compensation Plan for Non-Employee Directors. Each unit converts into one share of common stock, to be paid either in a lump sum or annual installments starting at least six months after she leaves the board.
The Travelers Companies, Inc. director Elizabeth Robinson reported an award of 729 shares of common stock-equivalent deferred stock units on February 3, 2026. These units were granted at a reported price of $288.23 per share under the company’s Amended and Restated 2023 Stock Incentive Plan and its Deferred Compensation Plan for Non-Employee Directors.
The deferred stock units will convert into shares of Travelers common stock on a one-for-one basis upon distribution. At the director’s election, distribution occurs either in a lump sum or in annual installments, beginning at least six months after her service as a director ends. Following this award, Robinson directly beneficially owns 12,186.626 shares.
The Travelers Companies, Inc. director Otis Clarence Jr received an award of 729 deferred stock units of common stock on February 3, 2026, valued at $288.23 per unit. After this grant, he beneficially owns 17,226.06 deferred stock units directly.
This total includes 258.322 deferred stock units accumulated since February 4, 2025 through the dividend reinvestment feature of Travelers’ Deferred Compensation Plan for Non-Employee Directors. The deferred stock units are scheduled to convert one-for-one into common shares upon distribution after the director’s board service ends.
The Travelers Companies, Inc. director Todd C. Schermerhorn reported an automatic award of 729 deferred stock units of common stock on February 3, 2026 at $288.23 per unit. These units were granted under Travelers’ Amended and Restated 2023 Stock Incentive Plan and its Deferred Compensation Plan for Non-Employee Directors.
After this award and prior dividend reinvestments, he beneficially owns 14,265.89 deferred stock units directly. The units convert into shares of Travelers common stock on a one-for-one basis, with payout in a lump sum or installments beginning at least six months after his board service ends.
The Travelers Companies, Inc. director Thomas B. Leonardi reported an equity award linked to company common stock. On February 3, 2026, he acquired 729 deferred stock units tied to Travelers common stock at a reference price of $288.23 per share.
After this award, Leonardi beneficially owns 5,834.305 shares-equivalent on a direct basis, including 79.942 deferred stock units accumulated through dividend reinvestment since February 4, 2025. These deferred stock units convert into common shares on a one-for-one basis and are distributed in a lump sum or installments after his board service ends.
The Travelers Companies, Inc. director Rafael Santana reported receiving an award of 729 deferred stock units of common stock on February 3, 2026 at a price of $288.23 per share. After this grant, he beneficially owns 4,622.338 common shares on a direct basis.
The units were granted under Travelers' Amended and Restated 2023 Stock Incentive Plan and its Deferred Compensation Plan for Non-Employee Directors. Each unit converts into one share of common stock, with distribution in a lump sum or installments starting at least six months after board service ends. The total includes 60.964 units accumulated through dividend reinvestment since February 4, 2025.
The Travelers Companies, Inc. director Russell G. Golden reported an award of 729 shares of common stock in the form of deferred stock units on February 3, 2026 at a reference price of $288.23 per share.
After this award, he beneficially owns a total of 5,260.663 shares directly. These deferred stock units were granted under the company’s Amended and Restated 2023 Stock Incentive Plan and the Deferred Compensation Plan for Non-Employee Directors. Each unit converts into one share of common stock upon distribution, which occurs in a lump sum or annual installments beginning at least six months after the director’s service ends.
The Travelers Companies, Inc. executive Jeffrey P. Klenk, EVP & President of Bond & Specialty Insurance, reported option exercises and a share sale. On January 23, 2026, he exercised stock options for 4,912 shares at $140.85 and 11,800 shares at $132.58, receiving equivalent amounts of Travelers common stock.
On the same date, he sold 16,712 shares of common stock in a market transaction at a weighted average price of $279.7746, with individual trades ranging from $279.60 to $280.25. After these transactions, he directly owned 6,075.303 shares of common stock and 9,016 stock options.
The Travelers Companies, Inc. director reported receiving additional deferred common stock units instead of cash fees. On 12/31/2025, the director acquired 150.83 deferred common stock units at a reference price of $290.06 per share, bringing the total directly owned deferred units to 11,457.626.
These deferred common stock units are granted under the company’s Deferred Compensation Plan for Non-Employee Directors and related director compensation plans. Each unit will convert on a one-for-one basis into a share of Travelers common stock when distributions are made. The director can elect to receive distributions in a lump sum or in annual installments, and the total includes 42.719 units added on December 31, 2025 through dividend reinvestment features.
The Travelers Companies, Inc. reported that one of its directors acquired deferred common stock units instead of cash fees. On 12/31/2025, the director received 159.45 deferred common stock units of Travelers common stock at a price of $290.06 per share, bringing the director’s total beneficial holding to 4,531.663 deferred common stock units.
According to the company’s Deferred Compensation Plan for Non-Employee Directors, these units will convert into shares of Travelers common stock on a one-for-one basis at distribution. Distribution occurs, at the director’s election, either in a lump sum or in annual installments. The filing also notes that the total includes 16.52 deferred common stock units acquired on December 31, 2025 through dividend reinvestment features of the directors’ compensation plans.
The Travelers Companies, Inc. executive reports equity disposition and updated holdings. A Form 4 filing shows that an officer of Travelers, serving as EVP and Chief Admin Officer, reported a transaction in the company’s common stock on 11/26/2025. The transaction, coded “G,” involved the disposition of 400 shares of common stock at a stated price of $0.
After this transaction, the reporting person beneficially owns 20,291.577 shares of Travelers common stock in a direct account and 1,702.641 shares through a 401(k) plan. The filing is made by one reporting person and reflects an update to that individual’s ownership position in Travelers stock.
The Travelers Companies, Inc. (TRV) reported an insider stock transaction by its Vice Chairman on a Form 4. On 11/25/2025, the executive exercised stock options to acquire 4,000 shares of common stock at an exercise price of $172.50 per share (coded as an "M" transaction). On the same date, the executive sold 2,000 shares at a weighted average price of $293.505 per share, 1,000 shares at $295, and 1,000 shares at $296 (all coded as "S" for sales).
After these transactions, the executive directly beneficially owned 255,085.534 shares of Travelers common stock. Additional indirect holdings included 1,710.706 shares in a 401(k) plan, 2,256 shares held by a spouse, and 250 shares held in trust for a stepson, with the executive disclaiming beneficial ownership of the spouse and trust shares.
The Travelers Companies, Inc. (TRV) executive reports share transfer. An officer of the company, listed as EVP, Strategic Development & President International, filed a Form 4 for a transaction dated 11/25/2025. The filing shows a Code G transaction, indicating a gift of 520 shares of common stock at a reported price of $0.
Following this transaction, the reporting person beneficially owns 117,596.149 shares of Travelers common stock in direct form and 340.501 shares held indirectly through a 401(k) plan. This is a routine insider ownership update and does not change the company’s overall capital structure.
The Travelers Companies, Inc. (TRV) reported an insider transaction by its EVP & Chief HR Officer on 11/24/2025. The executive exercised stock options to acquire 4,805 shares of common stock at an exercise price of $126.18 per share, then sold 4,805 shares of common stock at a price of $290 per share the same day.
After these transactions, the executive directly owned 3,818.549 shares of Travelers common stock. The related stock option grant, which was exercisable from 02/05/2022 and scheduled to expire on 02/05/2029, now shows 0 derivative securities remaining beneficially owned.
The Travelers Companies, Inc. (TRV) executive vice president and Co-Chief Investment Officer reported an equity transaction. On 11/21/2025, the insider exercised 5,000 stock options at an exercise price of $126.18 per share, acquiring common stock. That same day, the insider sold 5,000 shares of common stock at a weighted average price of $290.5698 per share, as noted in the footnotes.
After these transactions, the insider beneficially owned 22,562.385 shares of TRV common stock directly at one point following the option exercise, with the Form 4 showing 17,562.385 shares directly owned after the reported sale. Additional indirect holdings include 5,860.345 shares in a 401(k) plan and 9,986 shares held in trust, indicating continued significant ownership alignment with shareholders.
The Travelers Companies, Inc. (TRV) reported insider activity by its Vice Chairman on a Form 4. On 11/21/2025, the officer exercised 2,000 stock options at an exercise price of $172.50 per share and acquired the same number of common shares. That day, the officer also sold 1,000 shares at $291 and 1,000 shares at $292.
After these transactions, the officer directly owned 255,085.534 shares of Travelers common stock and held additional indirect interests, including shares in a 401(k) plan, shares held by a spouse, and shares held in trust for a stepson. The filing notes that the reporting person disclaims beneficial ownership of certain indirectly held shares.
The Travelers Companies (TRV) filed a Form 4 for its Vice Chairman, reporting option exercises and open‑market sales on 11/12/2025 and 11/13/2025. The officer exercised 2,000 options at $139.83 on 11/12 and 1,803 options at $172.5 on 11/13.
On 11/12, the filing shows sales of 1,000 shares at $287 and 1,000 shares at $288. On 11/13, it shows sales of 803 shares at $289 and 1,000 shares at $290. Following the reported transactions, direct ownership is listed as 255,085.534 shares. Indirect holdings are disclosed as 1,710.706 shares in a 401(k) plan, 2,256 held by spouse, and 250 in trust for a stepson, with a disclaimer of beneficial ownership for those shares.
The Travelers Companies (TRV) vice chairman reported option exercises and open‑market sales. From 11/07–11/11/2025, the insider exercised 7,000 stock options at an exercise price of $139.83 and sold 7,000 common shares in multiple transactions at prices including $280, $281, $282, a weighted average of $283.89, $285, and $286.
Following these transactions, directly held shares were 255,085.534, with an additional 1,710.706 shares listed under a 401(k) Plan. The filing notes shares held by a spouse and a trust for a stepson are disclaimed for beneficial ownership. Derivative holdings show 2,000 stock options remaining.
The Travelers Companies (TRV) EVP & CFO reported an option exercise and share sale. On 11/06/2025, the officer exercised 25,000 stock options at $139.83 per share and sold 25,000 common shares at a weighted average price of $278.2502.
Following these transactions, the officer beneficially owned 26,931.82 shares directly. Derivative holdings included 11,037 stock options remaining. The sales price reflects multiple trades within the $278.25 to $278.252 range.
The Travelers Companies (TRV) Form 4: an executive officer (EVP & President, Personal Insurance) exercised 8,572 stock options at $132.58 on 10/28/2025 and sold 6,742 shares at a weighted average price of $270.5946 and 1,830 shares at a weighted average price of $271.2455 the same day. Following these transactions, direct holdings were 33,638.031 shares, with an additional 1,874.659 shares held indirectly in a 401(k) plan. The option grant covered 8,572 underlying shares and 30,000 derivative securities remained beneficially owned after the transactions.
The filing reports that Elizabeth Robinson, a director of The Travelers Companies, Inc. (TRV), received 11,264.077 deferred common stock units on 09/30/2025 as non‑cash compensation under the company’s Deferred Compensation Plan for Non‑Employee Directors. These units convert one‑for‑one into shares of common stock upon distribution, which the director may elect to receive as a lump sum or in annual installments. The reported amount includes 43.583 additional deferred units acquired on 09/30/2025 via the plan’s dividend reinvestment feature. The Form 4 was signed by power of attorney on 10/01/2025.
Russell G. Golden, a director of The Travelers Companies, Inc. (TRV), reported receipt of deferred common stock units as director compensation. On 09/30/2025 he was granted 165.64 deferred common stock units under the companys director deferred compensation plan, credited in lieu of cash compensation at an indicated per-share value of $279.22. After the grants and related holdings, he beneficially owned 4,355.693 common stock units, which include 16.442 units received on 09/30/2025 from dividend reinvestment. These deferred units convert one-for-one into shares on distribution and may be paid either in a lump sum or in annual installments under the plan. The Form 4 was signed by power of attorney on 10/01/2025.